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has become an increasingly important goal of aging re-
search.Theputativeroleofnutritionalfactorsinmodifying
the risk of cognitive impairment haswidely been studied
(1–3). In this respect, disturbed iron homeostasis, which
may be genetically or environmentally determined, has
been coined as one suspected risk factor for age-related
cognitivedecline(4).
Iron deficiency is the most common nutritional defi-
ciencyworldwide,with aprevalenceof5%–20%among
adultsinWesterncountries(5–8).Adepletionofbodyiron
stores may result from insufficient dietary intake, ham-
pered absorption, or excessive losses (9,10). In addition,
regularwhole blood donationmay also lower body iron
concentrations(8).
Asaconstituentofvariousenzymes,ironisessentialfor
several physiological functions, including oxygen trans-
portandDNAsynthesis(11).Thebraininparticularhas
a high demand for iron not only because it is themain
oxygen-consumingorganinthehumanbodybutalsobe-
causemanyneurobiologicprocesses, includingmyelina-
tion, neurotransmitter synthesis, and synaptic plasticity,
are iron dependent (12–14). Consequently, one of the
major symptoms of iron deficiency is reduced cognitive
performance(4,10,13,14).
Although the effects of iron deficiency on cognitive
functioninghave frequentlybeen investigated inchildren
and young adults (15–19), research performed in older
personsisratherlimited(20–22).Irondeficiencyinolder
individualsmaybeduetopoordietaryhabits,gastrointes-
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Elevatedbodyironlevelsmightalsoimpairbrainfunc-
tioning.Becausebodyironconcentrationstendtoincrease
with age, particularly in women who reached the meno-
pause(26),increasedironconcentrationsaremorefrequent
inolderpersonsascomparedwithyoungadults;elevated






communities ofNorthernEuropean descent (28,29).This
mutationhasbeenassociatedwithneurodegenerativedisor-
ders (12,30), including Parkinson’s disease (31) andAl-
zheimer’sdisease(32,33).Itshouldbenoted,however,that
anumberof studiesdidnotfindanyevidence for such a




Despite the fact that both iron deficiency and elevated
ironlevelsfrequentlyoccurinolderindividualsandareas-
sociated with negative effects on cognitive functioning,
onlyasmallnumberofstudieshaveinvestigatedtheeffects
ofironparametersoncognitiveperformanceinlaterstages
of life. The results of these cross-sectional studies are
mixed.WhereasGaoandcolleagues(20)didnotfindany





was positively correlated with cognitive performance in
olderindividuals.


























to factorsother thansuboptimal folateconcentrations, in-
cluding serum vitamin B12 concentrations less than 200
pmol/L,self-reportedmedicaldiagnosisofrenalorthyroid
disorders,orself-reporteduseofmedicationsthatinfluence





rimotor speed, complex speed, information-processing
speed, andword fluencywas assessed at baseline and at
3-yearfollow-upbymeansofaneuropsychologicaltestbat-
tery, consisting of theVisualVerbalWord LearningTask
(38), the Stroop Color–Word Interference Test (39), the
Concept Shifting Test (40), the Letter Digit Substitution







concentration of the iron transport protein transferrin
(43,44);transferrinsaturation,whichisexpressedasthera-

























using a Qiamp 96 DNA blood kit (Qiagen, Venlo, The
Netherlands). DNA samples were stored at −80°C until
furtheranalysis.HFEC282Ygenotypewasdeterminedby
an automated method using minor-groove–binding DNA
oligonucleotides (MGB probes) (49). The presence of a
C282Y allelewas confirmed by conventional polymerase

















Cross-sectional analyses.—The cross-sectional associa-
tions between iron parameters and cognitive functioning
were assessed bymeans of hierarchical linear regression
analysis.The ironparameters considered relevant in rela-
tiontocognitiveperformanceweretotalserumiron,ferri-












education, alcohol consumption, smoking, BMI, physical
activity, C-reactive protein, hemoglobin, and APOE E4





ical activitywere confounders in our study.Although sex,
C-reactiveprotein,hemoglobin,andAPOEE4carrierstatus
were no actual confounders in our analyses,we included
thesevariablesascovariatestoenablecomparisonwithother








iron parameters and cognitive performance, regression



















tionsbetween ironparameters and cognitiveperformance




modelswere fitted for each iron parameter in relation to
eachofthefivecognitiveperformanceindices.Anunstruc-












minewhether the cross-sectional and longitudinal associa-
tionsbetweenironparametersontheonehandandcognitive













variances, the nonparametricMann–Whitney testwas per-
formedtotestfordifferencesinserumferritinandtransferrin













































TotalSample HFEC282YNoncarriers HFEC282YCarriers p*
n 818 685 80
Age(years) 60.3±5.6 60.3±5.6 59.8±5.6 .508
Femalesex(%) 28.4 27.9 30.0 .690
Levelofeducation,low/middle/high(%) 22.4/38.1/39.5 21.8/38.4/39.9 28.8/31.2/40.0 .282
Alcoholconsumption(g/day)† 12.5(4.4–23.5) 12.5(4.4–23.4) 14.3(3.7–26.1) .447
Currentsmoker(%) 20.4 20.0 23.8 .431
BMI(kg/m2) 26.6±3.6 26.5±3.6 26.6±3.5 .846
Physicalactivity(PASEscore) 152.8±68.6 153.3±69.3 153.1±65.4 .981
Blooddonor,current/former/never(%) 54.2/14.7/31.2 54.5/14.7/30.8 53.8/15.0/31.2 .993
APOEE4alleles,0/1/2(%)‡ 67.9/29.2/2.8 69.4/28.0/2.6 58.8/38.8/2.5 .134
SerumC-reactiveprotein(mg/dL)†,§ 1.1(0.6–2.3) 1.1(0.6–2.3) 1.1(0.6–2.1) .956
Serumhemoglobin(mmol/L) 8.9±0.7 8.9±0.7 9.0±0.7 .088
Serumironparameters
 Serumiron(mmol/L) 18.5±6.4 18.2±6.2 21.4±7.3 <.001
 Totaliron-bindingcapacity(mmol/L) 60.0±8.1 60.4±8.1 56.9±7.8 <.001
 Transferrinsaturation(%) 31.4±11.5 30.6±10.8 38.7±15.8 <.001
 Ferritin(mg/L)† 67.0(35.0–131.0) 65.0(34.0–125.0) 86.5(47.8–138.8) .063















Cross-Sectional Associations Between Serum Iron 
Parameters and Cognitive Functioning





cantly associated with decreased sensorimotor speed,
complexspeed,andinformation-processingspeed,after
adjustment forage, sex, levelofeducation,alcoholcon-
sumption, smoking, BMI, physical activity, C-reactive
protein,hemoglobin,andAPOEE4carrierstatus(Table3).
In addition, higher serum iron was associated with de-
creased sensorimotor speed (Table 3). In order to better
understandthestrengthof theassociations,whenthepre-
dictive value of serum iron for cognitive performance is
comparedwiththerelationshipwithageinthesameregres-
sionmodel, an increase of 10mmol/L serum iron corre-
sponds to a lower performance on sensorimotor speed





non–transferrin-bound ironwas not significantly associ-
atedwithcognitiveperformance.
Theobservedassociationsbetween ironparameters and




























APOEE4Noncarriers APOEE4Carriers p* APOEE4Noncarriers APOEE4Carriers p
n 473 209 47 33
Serumiron(mmol/L) 18.2±6.5 18.1±5.8 .966 21.2±7.7 21.6±6.9 .819
Totaliron-bindingcapacity(mmol/L) 60.5±8.2 60.2±7.7 .691 55.5±6.4 58.8±9.2 .064
Transferrinsaturation(%) 30.6±11.1 30.6±9.9 .958 39.0±16.3 38.4±15.3 .862
Ferritin(mg/L)† 67.0(35.0–131.0) 63.0(30.0–119.0) .251 91.0(50.0–139.0) 79.0(26.0–147.0) .479
Non–transferrin-boundiron(mmol/L)‡ 2.4±0.9 2.4±0.8 .369 2.8±1.0 2.9±1.1 .661










SerumIron p Ferritin p Non–Transferrin-BoundIron p
Memory 794 −.019 .807 .002 .951 .070 .362
Sensorimotorspeed 789 −.185 .012 −.073 .033 .141 .054
Complexspeed 788 −.081 .296 −.077 .019 .081 .266
Information-processingspeed 791 −.109 .141 −.069 .046 .078 .291
Wordfluency 794 −.050 .519 −.062 .092 .057 .462
Note:*Adjustedforthecovariatesage,sex,levelofeducation,alcoholconsumption,smoking,bodymassindex,physicalactivity,APOEE4carrierstatus,serum
C-reactiveprotein,andhemoglobinconcentrationinhierarchicallinearregressionanalyses.














Longitudinal Associations Between Serum Iron 
Parameters and Cognitive Functioning
Cognitive performance significantly declined over the
3-year follow-up period on the domains of sensorimotor
speed (mean change [95%CI]=−0.08 [−0.11 to−0.05],
p=.000),complexspeed(meanchange[95%CI]=−0.06
[−0.10 to −0.02], p = .004), and information-processing
speed (mean change [95%CI]=−0.11 [−0.15 to−0.08],















for serum iron andp = .088 for ferritin), although blood





functioning (Table 4), implying that the rate of cognitive
changeover3yearsdidnotvaryaccordingtobodyiron
concentrations.However,stratifyingouranalysesbydonor
status indicated that higher serum iron significantlypre-
dictedlessdeclineinsensorimotorspeedover3yearsin
non-donors (parameterestimate= .005,p= .010ascom-
paredwithparameterestimate=−.001,p= .253inblood
donors) and less decline inword fluency over 3 years in
blooddonors(parameterestimate=.006,p=.012ascom-
paredwith parameter estimate=−.004,p = .165 in non-
donors), indicating effectmodification bydonor status.







Associations Between the HFE C282Y Mutation and 
Cognitive Functioning



















SerumIron p Ferritin p Non–Transferrin-BoundIron† p
Memory 800 .002 .307 −.001 .292 .000 .965
Sensorimotorspeed 799 .001 .396 .000 .806 .001 .925
Complexspeed 798 −.002 .086 −.001 .221 −.016 .052
Information-processingspeed 799 .001 .501 .000 .578 −.005 .446







baseline, serum iron appeared to be negatively related to
sensorimotorspeedonly.Memoryprocesses,on theother
hand,didnot seem tobe related to ferritinnor anyother





factors cannotbe influencedbycognitive functioning, in-
vestigating the associations between HFE genotype and
cognitive performance has the benefit of reducing con-
foundingandrulingoutthepossibilityofreversecausation
(60). In thepresentstudy,wefoundthat theHFEC282Y
mutationwas associatedwith significantly increasedcon-
centrationsofserumironandnon–transferrin-bound iron,
aswell as a statistically nonsignificant increase in serum
ferritin.Contrarytoexpectation,wedidnotfindanyasso-
ciationsbetweenHFEC282Ygenotypeandcognitivefunc-





mon polymorphism of theHFE gene, H63D, which has
been found to interactwith theHFEC282Ygenotype in
determining individual iron levels (28,61). Future studies
investigating theassociationsbetweenHFEgenotypeand
cognitive functioning might increase statistical power by








involved in neurodegenerative disorders characterized by
irondepositioninthebrain(47,62).Theputativerelationship
between non–transferrin-bound iron and cognitive perfor-
mance,however,hasnotbeeninvestigatedbefore.Thepres-
ent resultsdonotoffersupport foranassociationbetween





concentrations (63). In hemochromatosis homozygotes,










Although elevated serum ferritin concentrations gener-





as a covariate in the statisticalmodels.Posthoc analyses













between APOE E4 carrier status and serum ferritin in
affectingcognitiveperformance.
Todate,onlyafewotherpopulation-basedstudieshave
investigated the relationshipbetween ironparameters and






transferrinandcognitive functioning, that is,memory,vi-
suospatialskills,andabstractreasoning,inasmallsample
of67menand70women.However, this associationwas
not corrected forpotential confounders, such as age, sex,
BMI,andalcoholconsumption.










levels and cognitive performance. However, although the
number ofmen in our sample (n = 586)was comparable
withthenumberofmenincludedinthestudybyLamand















It is worth noting that the prevalence of depleted iron
storesinourstudysamplewasslightlyhigherthanthatre-
ported in other population-based studies in older individ-
uals (ie, 5.3% as compared with 0.3%–3%) (6,27). In
addition, our study showed a lower percentageof ferritin
levelsabovetheuppernormallimitthanotherstudiesper-















only predicted less decline in sensorimotor speed over 3










statistically significant, serum ferritin showed a greater









worthnoting that they arenot likely tobedue todiurnal




a proxymeasure for brain iron levels, even though the
exact correlation between central and peripheral iron
levels is unclear. Nonetheless, epidemiological studies








volunteers, the use of serum iron parameters should be
consideredashortcoming.
Themain strengths of the present study are the use of
longitudinaldata,themeasurementofseveralironparame-
ters aswell asHFE C282Y genotype, the use of a large
community-basedsample,andavery lowattrition rate in
thelongitudinalphase(2%)(37).Inaddition,thecognitive
test battery administered in the present study has been




us to investigate the relationshipbetween ironparameters
and cognitive functioningwithin these individual groups.
Therelevanceoftakingintoaccountdonorstatusinpopulation-
based studies is emphasizedby thepresentfinding that
regularwholeblooddonationmaymodifytheassociations







between iron parameters and cognitive performance, as
well as the lack of a relationship betweenHFE C282Y
genotypeandcognitivefunctioning,suggeststhatthereis
no clear-cut relationship between serum iron parameters
andcognitivefunctioningorage-relatedcognitivedecline
in older community-dwelling individuals. However, the
presentstudyoffers indications foramore intricate rela-




Toour knowledge, our study is thefirst to address the
putative associations between theHFE C282Y mutation
andcognitiveperformanceinhealthyolderindividuals,as
well as the possible interactions between ironparameters
andAPOEE4carrier statusordonor status in relation to
cognitive functioning. Prospective studies using large
population-basedsamplesareneededtofurtherinvestigate
the associationsbetween ironparameters and cognitive
SCHIEPERS ET AL.1320
performanceandtoestablishwhetherthisassociationmay
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